Beta blockers to reduce mortality and cardiovascular complications after noncardiac surgery

January 1997

    There's a lot of talk about using beta blockers to reduce mortality and cardiovascular complications after noncardiac surgery.

    Researchers say this could save 25,000 lives a year.

    Atenolol (Tenormin) is being given to surgical patients with CHD...or those at risk for CHD.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote